Severe hepatitis induced by cyproterone acetate: Role of corticosteroids. A case report

Annals of Hepatology

Volumn 12, Issue 1, 2013, Pages 152-155

  Abenavoli, Ludovico ^a,c   Milic, Natasa ^b   Beaugrand, Michel ^c  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c HÔPITAL JEAN VERDIER   (France)

Author keywords

Budesonide; Hepatotoxicity; Interface hepatitis; Prednisone

Indexed keywords

ALANINE AMINOTRANSFERASE; BICALUTAMIDE; BILIRUBIN; BUDESONIDE; CORTICOSTEROID; CYPROTERONE ACETATE; FATTY ACID; GOSERELIN; PREDNISONE; URSODEOXYCHOLIC ACID; ANTINEOPLASTIC AGENT; CHOLAGOGUE; GLUCOCORTICOID;

AGED; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL EVALUATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; JAUNDICE; LIVER BIOPSY; LIVER CIRRHOSIS; LOW DRUG DOSE; MALE; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; PRURITUS; TOXIC HEPATITIS; ADENOCARCINOMA; PROSTATE TUMOR;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS; BUDESONIDE; CHOLAGOGUES AND CHOLERETICS; CYPROTERONE ACETATE; DRUG-INDUCED LIVER INJURY; GLUCOCORTICOIDS; HUMANS; MALE; PREDNISONE; PROSTATIC NEOPLASMS; URSODEOXYCHOLIC ACID;

MLCS; MLOWN;

EID: 84878765273     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31399-7     Document Type: Article

References (15)

1. Chodak G, Gomella L, Phung de H. Combined androgen blockade in advanced prostate cancer: looking back to move forward. Clin Genitourin Cancer 2007; 5: 371-8.
2. Savidou I, Deutsch M, Soultati AS, Koudouras D, Kafiri G, Dourakis SP. Hepatotoxicity induced by cyproterone acetate: a report of three cases. World J Gastroenterol 2006; 12: 7551-5.
3. Brahm J, Brahm M, Segovia R, Latorre R, Zapata R, Poniachik J, et al. Acute and fulminant hepatitis induced by flutamide: case series report and review of the literature. Ann Hepatol 2011; 10: 93-8.
4. Thole Z, Manso G, Salgueiro E, Revuelta P, Hidalgo A. Hepatotoxicity induced by antiandrogens: a review of the literature. Urol Int 2004; 73: 289-95.
5. Savidou I, Deutsch M, Soultati AS, Koudouras D, Kafiri G, Dourakis SP. Hepatotoxicity induced by cyproterone acetate: a report of three cases. World J Gastroenterol 2006; 12: 7551-5.
6. Teschke R, Schwarzenboeck A, Hennermann KH. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol 2008; 66(6): 758-66.
7. Watanabe S, Yamasaki S, Tanae A, Hibi I, Honna T. Three cases of hepatocellular carcinoma among cyproterone users. Ad hoc comitte on androcur users. Lancet 1994; 344: 1567-8.
8. Russmann S, Jetter A, Kullak-Ublick GA. Pharmacogenetics of drug-induced liver injury. Hepatology 2010; 52: 748-61.
9. Kasper P. Cyproterone acetate: a genotoxic carcinogen? Pharmacol Toxicol 2001; 88: 223-31.
10. Baltogiannis D, Giannakopoulos X, Charalabopoulos K, Sofikitis N. Monotherapy in advanced prostate cancer: an overview. Exp Oncol 2004; 26: 185-91.
11. Friedman G, Lamoureux E, Sherker AH. Fatal fulminant hepatic failure due to cyproterone acetate. Dig Dis Sci 1999; 44: 1362-3.
12. Manso G, Thole Z, Salgueiro E, Revuelta P, Hidalgo A. Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system. Pharmacoepidemiol Drug Saf 2006; 15: 253-9.
13. Miquel M, Soler A, Vaqué A, Ojanguren I, Costa J, Planas R. Suspected cross-hepatotoxicity of flutamide and cyproterone acetate. Liver Int 2007; 27: 1144-7.
14. Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci 2011; 56: 958-76.
15. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, Vierling JM; American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193-213.